Fatigue News and Research

RSS

Carbohydrates boost endurance sports performance

Carbohydrates are the body's main energy source during high-intensity, prolonged running, a new study published in Journal of Applied Physiology reports.

16 Dec 2015

U.S. has sufficient capacity for treating Ebola outbreak but financial, resource challenges remain as hurdle

The United States has sufficient capacity for treating another outbreak of the Ebola virus, but financial, staffing and resource challenges remain a hurdle for many hospitals and health systems attempting to maintain dedicated treatment centers for highly infectious diseases, according to new study released today.

12 Dec 2015

High carbohydrate regime may counter effects of sleep deprivation among athletes

Getting enough sleep is an essential part of any athlete's training programme, but a study in the Journal of Sports Sciences reveals intensive bouts of exercise can make it hard to get 40 winks. Suspecting that intense exercise can lead to sleep disturbance, scientists from Loughborough University studied the effects of two nine day periods of heavy training on 13 highly trained cyclists.

12 Dec 2015

Instratek announces record revenue growth for 10th straight year and release of ToeTac implant

Instratek, a privately held medical device company focused on minimally invasive endoscopic surgery and extremity implants, announces record revenue growth for the 10th straight year. The company recorded solid year over year revenue growth of its extremity endoscopy business and extremity implants, including the recently released nitinol fixation staple, STAPiX.

12 Dec 2015

Alecensa (alectinib) approved for treatment of people with advanced ALK-positive NSCLC

The U.S. Food and Drug Administration today approved Alecensa (alectinib) to treat people with advanced (metastatic) ALK-positive non-small cell lung cancer (NSCLC) whose disease has worsened after, or who could not tolerate treatment with, another therapy called Xalkori (crizotinib).

11 Dec 2015

Right atrial function could be prognostic in PAH

Right atrial function is impaired in patients with pulmonary arterial hypertension and may indicate right ventricular overload and failure, research suggests.

11 Dec 2015

FDA grants Fast Track status to Cardiorentis' Ularitide for treatment of ADHF

Cardiorentis AG, a privately held biopharmaceutical company, today announced that the U.S. Food and Drug Administration has granted Fast Track status to Ularitide, an investigational therapy for the treatment of acute decompensated heart failure (ADHF).

11 Dec 2015

Capecitabine increases disease-free survival for HER2-negative breast cancer patients

Treatment with the chemotherapy agent capecitabine increased disease-free survival for women with HER2-negative breast cancer that was not eliminated by presurgery chemotherapy, according to results from the phase III CREATE-X clinical trial presented at the 2015 San Antonio Breast Cancer Symposium, held Dec. 8-12.

11 Dec 2015

Lilly, Merck announce another immuno-oncology collaboration

Eli Lilly and Company and Merck, known as MSD outside the United States and Canada, today announced another immuno-oncology collaboration that will evaluate abemaciclib (LY2835219), Lilly's cyclin-dependent kinase (CDK) 4 and 6 inhibitor, and Merck's KEYTRUDA (pembrolizumab) in a Phase I study across multiple tumor types.

10 Dec 2015

Gene may play role in protecting breast cancer patients from developing chemobrain

A team of researchers from the National University of Singapore has established that variation of a gene may have a role in protecting cancer patients from developing chemotherapy-induced cognitive impairment, commonly known as 'chemofog' or 'chemobrain'.

9 Dec 2015

Study emphasizes vital role of sleep in maintaining good emotional balance in our life

Cranky or grumpy after a long night? Your brain's ability to regulate emotions is probably compromised by fatigue. This is bad news for 30 percent of American adults who get less than six hours of sleep per night, according to the Centers for Disease Control and Prevention.

9 Dec 2015

Plasmacytoid dendritic cells may not contribute to late-stage lupus

For years, biomedical researchers have suspected that a specific set of immune cells are responsible for causing disease in lupus patients, but until now they haven't known for sure one way or the other.

8 Dec 2015

Takeda presents Phase 3 TOURMALINE-MM1 data for multiple myeloma at ASH 2015

Takeda Pharmaceutical Company Limited today announced results from the TOURMALINE-MM1 trial presented at the 57th Annual Meeting and Exposition of the American Society of Hematology (ASH), showing that treatment with NINLARO (ixazomib) capsules is effective in extending progression free survival (PFS) with a manageable tolerability profile in patients with relapsed and/or refractory multiple myeloma.

8 Dec 2015

Tips to help lower risk of sports-related concussions

With scholastic sports such as football now in full swing, the potential for head injuries increases. Unfortunately, an estimated 3.8 million recreational and athletic concussions occur annually in the United States, according to the Centers for Disease Control and Prevention.

7 Dec 2015

Ibrutinib more effective than traditional chemotherapy in older untreated patients with CLL

A multi-center, international, randomized, Phase III study of older untreated patients with chronic lymphocytic leukemia (CLL) demonstrated that ibrutinib, a kinase inhibitor, is significantly more effective than traditional chemotherapy with chlorambucil.

7 Dec 2015

Combining medications may increase HBsAg loss in HBV patients

Combining tenofovir disoproxil fumarate with pegylated interferon alfa-2a may improve the chances of hepatitis B surface antigen loss in patients with hepatitis B virus infection, suggests a randomised trial.

3 Dec 2015

Preventable comorbidities common in cerebral palsy patients

Medical comorbidities are common in patients with cerebral palsy and may impact on their mobility, report researchers.

2 Dec 2015

Lexicon announces top-line results from TELECAST Phase 3 study of telotristat etiprate

Lexicon Pharmaceuticals, Inc. announced today that top-line data from its TELECAST Phase 3 study showed results of telotristat etiprate in treating carcinoid syndrome in cancer patients with metastatic neuroendocrine tumors consistent with the clinical benefit observed in its pivotal TELESTAR study.

1 Dec 2015

Boston Scientific obtains FDA approval, CE Mark for AngioJet ZelanteDVT catheter to treat DVT

Boston Scientific has received United States (U.S.) Food and Drug Administration approval and CE Mark for the AngioJet ZelanteDVT thrombectomy catheter to treat deep vein thrombosis (DVT) in large-diameter upper and lower limb peripheral veins.

30 Nov 2015

FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

Today the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple myeloma who have received one to three prior medications.

30 Nov 2015

Fatigue News and Research

Carbohydrates boost endurance sports performance

U.S. has sufficient capacity for treating Ebola outbreak but financial, resource challenges remain as hurdle

High carbohydrate regime may counter effects of sleep deprivation among athletes

Instratek announces record revenue growth for 10th straight year and release of ToeTac implant

Alecensa (alectinib) approved for treatment of people with advanced ALK-positive NSCLC

Right atrial function could be prognostic in PAH

FDA grants Fast Track status to Cardiorentis' Ularitide for treatment of ADHF

Capecitabine increases disease-free survival for HER2-negative breast cancer patients

Lilly, Merck announce another immuno-oncology collaboration

Gene may play role in protecting breast cancer patients from developing chemobrain

Study emphasizes vital role of sleep in maintaining good emotional balance in our life

Plasmacytoid dendritic cells may not contribute to late-stage lupus

Takeda presents Phase 3 TOURMALINE-MM1 data for multiple myeloma at ASH 2015

Tips to help lower risk of sports-related concussions

Ibrutinib more effective than traditional chemotherapy in older untreated patients with CLL

Combining medications may increase HBsAg loss in HBV patients

Preventable comorbidities common in cerebral palsy patients

Lexicon announces top-line results from TELECAST Phase 3 study of telotristat etiprate

Boston Scientific obtains FDA approval, CE Mark for AngioJet ZelanteDVT catheter to treat DVT

FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News